The latest closing stock price for MoonLake Immunotherapeutics as of January 31, 2025 is 45.99.
An investor who bought $1,000 worth of MoonLake Immunotherapeutics stock at the IPO in 2020 would have $3,384 today, roughly 3 times their original investment - a 44.70% compound annual growth rate over 4 years.
The all-time high MoonLake Immunotherapeutics stock closing price was 63.86 on February 12, 2024.
The MoonLake Immunotherapeutics 52-week high stock price is 64.98, which is 41.3% above the current share price.
The MoonLake Immunotherapeutics 52-week low stock price is 37.55, which is 18.4% below the current share price.
The average MoonLake Immunotherapeutics stock price for the last 52 weeks is 47.71.
An investor who bought $1,000 worth of MoonLake Immunotherapeutics stock at the IPO in 2020 would have $3,384 today, roughly 3 times their original investment - a 44.70% compound annual growth rate over 4 years.
The all-time high MoonLake Immunotherapeutics stock closing price was 63.86 on February 12, 2024.
The MoonLake Immunotherapeutics 52-week high stock price is 64.98, which is 41.3% above the current share price.
The MoonLake Immunotherapeutics 52-week low stock price is 37.55, which is 18.4% below the current share price.
The average MoonLake Immunotherapeutics stock price for the last 52 weeks is 47.71.